Nano-X Imaging Ltd. Q3 2025 Earnings Recap

NNOX Q3 2025 November 20, 2025

Get alerts when NNOX reports next quarter

Nano-X Imaging Ltd. delivered solid progress in Q3 2025, outlining a strategic roadmap for growth while positioning itself for over $35 million in revenues for 2026.

Earnings Per Share Miss

$-0.65 vs $-0.15 est.

-333.3% surprise

Revenue Miss

3447000 vs 3993750 est.

-13.7% surprise

Market Reaction

1-Day +13.86%

5-Day +49.17%

30-Day +7.24%

See NNOX alongside your other holdings

Add to your portfolio — free

Key Takeaways

Expanded agreements in Europe signal strong demand for Nano-X ARC and reinforce its European strategy.
Launch of the next-generation Nano-X ArcX system is set to enhance market reach and adaptability, including AI compatibility.
Acquisition of Vaso Healthcare IT bolsters Nano-X's capabilities in integrating imaging AI, enriching its service offering and market potential.
Progress in operational efficiency and production capabilities ensures a solid foundation for sustainable growth moving forward.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit NNOX on AllInvestView.

Previous Q2 2025